128 related articles for article (PubMed ID: 32142761)
21. [Assessment of oxalate concentration in serum and urine of children with renal stones].
Jadeszko I; Porowski T; Zoch-Zwierz WM; Wasilewska AM; Hackiewicz L
Wiad Lek; 2005; 58 Suppl 1():20-4. PubMed ID: 16060079
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive metabolic profile of phenolic acids and flavonoids in Glechomae Herba using ultra-high-performance liquid chromatography coupled to quadrupole-time-of-flight tandem mass spectrometry with diagnostic ion filtering strategy.
Luo Y; Lai CJ; Zhang J; Feng Y; Wen Q; Tan T
J Pharm Biomed Anal; 2019 Feb; 164():615-629. PubMed ID: 30469111
[TBL] [Abstract][Full Text] [Related]
23. A comparative study on several models of experimental renal calcium oxalate stones formation in rats.
Liu J; Cao Z; Zhang Z; Zhou S; Ye Z
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):83-7. PubMed ID: 17393118
[TBL] [Abstract][Full Text] [Related]
24. UFLC-Q-TOF/MS based screening and identification of the metabolites in plasma, bile, urine and feces of normal and blood stasis rats after oral administration of hydroxysafflor yellow A.
Jin Y; Wu L; Tang Y; Cao Y; Li S; Shen J; Yue S; Qu C; Shan C; Cui X; Zhang L; Duan JA
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1012-1013():124-9. PubMed ID: 26827279
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous determination of four flavonoids and one phenolic acid in rat plasma by LC-MS/MS and its application to a pharmacokinetic study after oral administration of the Herba Desmodii Styracifolii extract.
Sun D; Dong L; Guo P; Yan W; Wang C; Zhang Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():66-73. PubMed ID: 23831698
[TBL] [Abstract][Full Text] [Related]
26. [The effect of takusha and kagosou on calcium oxalate renal stones in rats].
Yamaguchi S; Jihong L; Utsunomiya M; Yoshioka T; Okuyama A; Koide T; Sugiyama K
Hinyokika Kiyo; 1995 Jun; 41(6):427-31. PubMed ID: 7645450
[TBL] [Abstract][Full Text] [Related]
27. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
[TBL] [Abstract][Full Text] [Related]
28. [Influence of electroacupuncture combined with intensive moxibustion intervention on pathological changes of kidney and ureter tissues, plasma and uterine Ca2+, creatinine, and urea nitrogen levels in calcium oxalate stone rats].
Wang W; Zhang J
Zhen Ci Yan Jiu; 2012 Dec; 37(6):464-9. PubMed ID: 23383455
[TBL] [Abstract][Full Text] [Related]
29. A Systematic Study of the Metabolites of Dietary Acacetin in Vivo and in Vitro Based on UHPLC-Q-TOF-MS/MS Analysis.
Yin J; Ma Y; Liang C; Gao J; Wang H; Zhang L
J Agric Food Chem; 2019 May; 67(19):5530-5543. PubMed ID: 31025561
[TBL] [Abstract][Full Text] [Related]
30. UHPLC-Q-TOF-MS/MS method based on four-step strategy for metabolites of hinokiflavone in vivo and in vitro.
Chen Y; Feng X; Li L; Zhang X; Song K; Diao X; Sun Y; Zhang L
J Pharm Biomed Anal; 2019 May; 169():19-29. PubMed ID: 30831449
[TBL] [Abstract][Full Text] [Related]
31. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Parker WR; Asplin JR
Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo metabolic investigation of the Palbociclib by UHPLC-Q-TOF/MS/MS and in silico toxicity studies of its metabolites.
Chavan BB; Tiwari S; G S; Nimbalkar RD; Garg P; R S; Talluri MVNK
J Pharm Biomed Anal; 2018 Aug; 157():59-74. PubMed ID: 29772457
[TBL] [Abstract][Full Text] [Related]
33. Influence of hypercalcic and/or hyperoxalic diet on calcium oxalate renal stone formation in rats.
Bardouri M; Neffati F; Trimeche M; Elhani A; Fadhel Najjar M; Sakly R
Scand J Urol Nephrol; 2006; 40(3):187-91. PubMed ID: 16809257
[TBL] [Abstract][Full Text] [Related]
34. Identification of chemical constituents and rat metabolites of Kangxianling granule by HPLC-Q-TOF-MS/MS.
Zheng L; Fang L; Cong H; Xiang T; Xue M; Yao Z; Wu B; Lin W
Biomed Chromatogr; 2015 Nov; 29(11):1750-8. PubMed ID: 25990409
[TBL] [Abstract][Full Text] [Related]
35. UPLC-Q-TOF/MS-Based Metabolic Profiling Comparison of Two Major Bioactive Components and Their Metabolites in Normal and CKD Rat Plasma, Urine and Feces Following Oral Administration of Fructus Corni Extract.
Zhao M; Tao J; Du L; Jiang S; Qian D; Duan J
J Chromatogr Sci; 2017 Sep; 55(8):857-865. PubMed ID: 28541451
[TBL] [Abstract][Full Text] [Related]
36. Screening and identification of three typical phenylethanoid glycosides metabolites from Cistanches Herba by human intestinal bacteria using UPLC/Q-TOF-MS.
Li Y; Zhou G; Peng Y; Tu P; Li X
J Pharm Biomed Anal; 2016 Jan; 118():167-176. PubMed ID: 26551535
[TBL] [Abstract][Full Text] [Related]
37. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
[TBL] [Abstract][Full Text] [Related]
38. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
Thamilselvan S; Menon M
BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
[TBL] [Abstract][Full Text] [Related]
39. A simple and sensitive UHPLC-Q-TOF-MS/MS method for sophoricoside metabolism study in vitro and in vivo.
Zhang X; Yin J; Liang C; Sun Y; Zhang L
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():193-208. PubMed ID: 28750233
[TBL] [Abstract][Full Text] [Related]
40. Can 24-hour urine stone risk profiles predict urinary stone composition?
Torricelli FC; De S; Liu X; Calle J; Gebreselassie S; Monga M
J Endourol; 2014 Jun; 28(6):735-8. PubMed ID: 24460026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
